We use cookies essential for this site to function well. Please click "Accept" to help us improve its usefulness with additional cookies. Learn about our use of cookies, and collaboration with select social media and trusted analytics partners here.

Accept Use minimal essential cookies
Pharmaceuticals & Medical Products
Pharmaceuticals & Medical Products

Insights on Pharmaceuticals & Medical Products

Article

On pins and needles: Tracking COVID-19 vaccines and therapeutics

– Key stakeholders will need to continue to monitor and adapt to new data and new variants emerging across the globe to respond effectively.
Interview

Can a Japanese pharmaceutical become a social innovator?
– Santen CIO Minori Hara explains how IT is enabling the ophthalmological company to deliver a holistic sense of well-being around... eye health.
Article

Operations can launch the next blockbuster in pharma
– Pharma operations has long centered on avoiding missteps, especially in quality and compliance. But with the Fourth Industrial... Revolution, operations could launch pharma’s next innovation blockbuster.
Article

First-time launchers in the pharmaceutical industry
– Increasingly, small biopharmaceutical companies are launching their new drugs themselves rather than relying on large pharma companies... to do it for them. How can they get it right the first time?
Article

How Japan’s medtech leaders can use M&A to create a competitive advantage
– Companies that invest inorganically during a downturn generally emerge stronger than their competitors. Japanese medtech companies... have the cash, the incentive, and the opportunity to do just that.
Article

A new portfolio model for biotech
– An emerging model for biotech companies could disrupt the R&D landscape and open up new ways to invest, motivate teams, and... shape the innovation pipeline.
Article

The risks and challenges of the global COVID-19-vaccine rollout
– A realistic assessment of the heroic effort to administer billions of doses of COVID-19 vaccines to an agonized global population... is necessary—the stakes could not be higher.
Article

A call to action: Opportunities and challenges for CGTs in Europe
– The speed at which scientific breakthroughs in cell and gene therapy translate into advances in European healthcare could depend... on how quickly stakeholders address some uniquely European challenges.
Article

Moving digital health forward: Lessons on business building
– Building a successful digital health business involves several strategic steps, as illustrated through the lens of six digital... health start-ups.

Special collection

Future of pharma operations
Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations. Contact us to learn more.

Coronavirus vaccines progress: What’s next?
The rapid development of the COVID-19 vaccines is having a profound effect on the world. This collection takes a closer look at the development, rollout and future of vaccines.

McKinsey insights on cell and gene therapy

Continuing advances in cell and gene therapy (CGT) are transforming how we treat and potentially cure certain diseases. This collection of articles provides an in-depth look at the opportunities and challenges ahead and the implications for stakeholders in this fast-evolving field. Contact us to learn more.

The rise of health technology
Health technology continues to push the boundaries of how healthcare is delivered and has the power to create breakthroughs in our understanding of disease. This collection of articles and interviews explores the evolving role of health technology in the life-sciences sector and implications for key stakeholders. Contact us to learn more about our work in this field.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

Learn more

More insights

Executive Briefing

COVID-19: Implications for business
– Our latest perspectives on the coronavirus outbreak, the twin threats to lives and livelihoods, and how organizations can prepare... for the next normal.
Article

Getting to work: Employers’ role in COVID-19 vaccination
– Employers can consider a set of actions that supports COVID-19-vaccine adoption among employees by building conviction and making... vaccination as convenient and “costless” as possible.
Article

All in the mix: Why US COVID-19 cases rose and fell, and what comes next
– Some people get out and about more than others. That might be a key and overlooked factor in recent declines in US COVID-19 case... counts—and could have implications as society reopens.
Interview

Looking ahead in US consumer health: An interview with Scott Melville
– Self-care, digital health, and e-commerce will all play a central role in shaping the future of wellness, says the CEO of the... Consumer Healthcare Products Association.
Article

A new portfolio model for biotech
– An emerging model for biotech companies could disrupt the R&D landscape and open up new ways to invest, motivate teams, and... shape the innovation pipeline.
Article

Making quality assurance smart
– Pharmaceutical and medtech companies can dramatically improve quality assurance processes by applying a ‘smart quality’... lens and cutting-edge technologies.
Article

Smart quality: Reimagining the way quality works
– Pharma and medtech companies that adopt a proactive approach to managing the quality function can generate value far beyond improved... regulatory compliance.
Article

Biopharma 2020: A landmark year and a reset for the future
– Biopharma in 2020 has shown what it can achieve when it works at its best. How can the industry build on this renewed sense of... purpose in the years ahead?
Article

COVID-19 vaccines meet 100 million uncertain Americans
– More than 100 million Americans are uncertain about vaccination. Public- and private-sector leaders can take action to support... adoption, including incremental investment in the range of $10 billion.
Article

The resilience imperative for medtech supply chains
– The COVID-19 pandemic highlighted issues with supply chains around the world. As medtech companies prepare for the next normal,... they have a mandate to rebuild their supply chains with resilience as a new priority.
Article

Ready for launch: Reshaping pharma’s strategy in the next normal
– As pharmaceutical companies reshape their commercial models to prepare for the uncertainties ahead, personalization and digital... enablement will be crucial to launch success in the new environment.
Sorry, we couldn't find any results. Try removing some filters.
View more

More from this practice

McKinsey Cancer Center

The McKinsey Cancer Center helps life sciences organizations discover, develop, and distribute more effective medicines, deliver better care, and provide broader access to solutions that help patients and their families combat cancer.

Related practice

Connect with our Pharmaceuticals & Medical Products Practice

Contact